1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
10qk
10qk
Articles 

VisionSciences Inc. Reports Operating Results (10-Q)

February 11, 2010 | About:

VisionSciences Inc. (VSCI) filed Quarterly Report for the period ended 2009-12-31.

Visionsciences Inc. has a market cap of $42 million; its shares were traded at around $1.14 with and P/S ratio of 3.3. Visionsciences Inc. had an annual average earning growth of 27.5% over the past 5 years.

Highlight of Business Operations:

Net sales decreased $1.0 million, or 28%, in the third quarter of fiscal 2010 to $2.6 million compared to $3.6 million in the third quarter of fiscal 2009. During the third quarter of fiscal 2010, our medical segment s net sales of $1.8 million decreased by $0.9 million, or 34%, primarily attributable to lower sales in the ENT and TNE market ($1.3 million) and our industrial segment s net sales of $0.8 million decreased by $0.1 million, or 9%, primarily attributable to lower sales of our borescopes ($0.1 million) compared to the same period last year.

Net sales to the ENT and TNE markets decreased $1.3 million, or 71%, in the third quarter of fiscal 2010 to $0.6 million compared to $1.9 million in the third quarter of fiscal 2009. The decrease in net sales was primarily attributable to lower sales to Medtronic of our fiberscopes and videoscopes ($0.8 million) and digital processing units, a component of our videoscope product line ($0.2 million).

Net sales to the urology market increased $0.2 million, or 87%, in the third quarter of fiscal 2010 to $0.4 million compared to $0.2 million in the third quarter of fiscal 2009. The increase in net sales was primarily attributable to higher sales of our fiberscopes ($0.1 million) and EndoSheath disposables ($0.1 million).

Net sales of repairs, peripherals, and accessories decreased $0.1 million, or 18%, in the third quarter of fiscal 2010 to $0.5 million compared to $0.6 million in the third quarter of fiscal 2009. The decrease was primarily attributable to lower sales volume of peripherals and accessories for our ENT endoscopes ($0.1 million).

Gross profit decreased $0.4 million, or 54%, in the third quarter of fiscal 2010 to $0.4 million, or 13% of net sales, compared to $0.8 million, or 21% of net sales, in the third quarter of fiscal 2009. In the medical segment, gross profit decreased $0.4 million, or 98%, in the third quarter of fiscal 2010 compared to the same period last year. The decrease was primarily due to unfavorable overhead absorption as result of the lower sales volume ($0.3 million). In the industrial segment, gross profit increased by a marginal 2% in the third quarter of fiscal 2010 to $0.3 million compared to the same period last year. The increase was primarily attributable to manufacturing efficiencies.

Total operating expenses decreased $0.3 million, or 8%, in the third quarter of fiscal 2010 to $3.6 million compared to $3.9 million in the third quarter of fiscal 2009. Selling, general, and administrative (“SG&A”) expenses increased $0.5 million, or 20%, and research and development (“R&D”) expenses decreased $0.8 million, or 55%, compared to the same period last year.

Read the The complete Report

About the author:

10qk
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.4/5 (5 votes)

Comments

Please leave your comment:


Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK